Higher Gemcitabine Dose Was Associated With Better Outcome of Osteosarcoma Patients Receiving Gemcitabine‐Docetaxel Chemotherapy
2016 · Pediatric Blood & Cancer · 22 citations
https://doi.org/10.1002/pbc.26058
K
Kyung‐Nam Koh
Ulsan College(KR)
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
155
Papers
1.4K
Citations
19
h-index
47
i10-index
Kyung‐Nam Koh is an academic researcher from Ulsan College. The author has contributed to research in topics: Hematopoietic Stem Cell Transplantation & Acute Lymphoblastic Leukemia research & Childhood Cancer Survivors' Quality of Life. The author has an h-index of 19, co-authored 132 publications.
ORCID: 0000-0002-6376-672XPapers by this author
worksPrevalence of type 5 familial hemophagocytic lymphohistiocytosis in Korea and novel mutations in <i><scp>STXBP2</scp></i>
2015 · Clinical Genetics · 7 citations
https://doi.org/10.1111/cge.12682
High‐dose chemotherapy followed by autologous stem cell transplantation in pediatric patients with relapsed osteosarcoma
2023 · Pediatric Blood & Cancer · 2 citations
https://doi.org/10.1002/pbc.30233
Simultaneous rearrangements of <scp><i>TAL1</i></scp> and <scp><i>LMO2</i></scp> in T‐cell acute lymphoblastic leukemia
2013 · International Journal of Laboratory Hematology · 0 citations
https://doi.org/10.1111/ijlh.12179
MRI major and ancillary features of LI-RADS for diagnosis of pediatric malignant liver tumors
2025 · European Radiology · 0 citations
https://doi.org/10.1007/s00330-025-11775-y
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat